Application of LC-MS/MS method in pharmacokinetic study of multi-components from tea polyphenols in rats

Chinese Journal of New Drugs

Volumn 20, Issue 9, 2011, Pages 817-824

  Li, Qiu Sha ^a   Wang, Chang Yuan ^a   Han, Guo Zhu ^a   Zou, Ling Li ^a   Lü, Li ^a   Li, Nan ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Bioavailability; LC MS MS; Pharmacokinetics; Tea polyphenols

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN GALLATE; ESTER DERIVATIVE; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DISTRIBUTION VOLUME; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG ISOLATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; NONHUMAN; PHARMACOKINETICS; RAT; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TEA;

EID: 84863375649     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. GRAHAM H N. Green tea composition, consumption, and polyphenol chemistry[J]. Prev Med, 1992, 21(3): 334-350.
2. YOKOZOWA T, NAKAGAWA T. Antioxidative activity of green tea polyphenols in cholesterol fed rats[J]. Agric Food Chem, 2002, 50(12): 3549-3552.
3. ZHAO B L, LIU S L, CHEN Y S, et al. Scavenging effect of catechin on free radicals studied by molecular orbital calculation[J]. Zhongguo Yao Li Xue Bao, 1992, 13(1): 9-13.
4. 2005, 25(4):381-383.
5. MURASE T, NAGASAWA A, SUZUKI J, et al. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver[J]. Int Obes Relat Metab Disord, 2002, 26(11): 1459-1464.
6. KATIYAR S K, ELMETS C A. Green tea polyphenolic antioxidants and skin photoprotection[J]. Int J Oncol, 2001, 18(6): 1307-1313.
7. SABU M C, SMITHA K, KUTAN R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes[J]. J Ethnopharmacol, 2002, 83(1-2): 109-116.
8. YANG C S, CHUNG J Y, YANG G, et al. Tea and tea polyphenols in cancer prevention[J]. J Nutr, 2000, 130(2S Suppl): 472S-478S.
9. LAMBERT J D, YANG C S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols[J]. Mutat Res, 2003, 201(8): 523-524.
10. WILLIAMSON M P, MCCORMICK T G, NANCE C L, et al. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor CD4: Potential for HIV-1 therapy[J]. Allergy Clin Immunol, 2006, 118(6): 1369-1374.
11. CHEN L, LEE M J, LI H, et al. Absorption, distribution, and elimination of tea polyphenols in rats[J]. Drug Metab Dispos, 1997, 25(9): 1045-1050.
12. KIM S, LEE M J, HONG J, et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols[J]. Nutr Cancer, 2000, 37(1): 41-48.
13. FU T, LIANG J, HAN G, et al. Pharmacokinetic study of the main antoxidant active components of tea polyphenols in rats following single dose intravenous administration[J]. Asian J Pharmacodyn Pharmacokin, 2008, 9(2): 144-150.
14. FU T, LIANG J, HAN G, et al. Simultaneous determination of the major active components of tea polyphynols in rat plasma by a simple and specific HPLC assay[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2008, 875(2): 363-367.
15. LI Q, ZOU L, FU T, et al. Excretion of four catechins in tea polyphenols in rats[J]. Chin Herb Med, 2009, 1(1): 59-65.
16. MATUSZEWSKI B K, CONSTANZER M L, CHAVEZ C M. Strategies for the assessment of matrix effect in quantitative bioanalytical methord based on HPLC-MS/MS[J]. Anal Chem, 2003, 75(13): 3019-3030.
17. 1992, 13(2): 180-182.
18. LIN L C, WANG M N, TSENG T Y, et al. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution[J]. J Agric Food Chem, 2007, 55(4): 1517-1524.